Amigro Biopharma now has three production bases located in industrial parks in Chongqing and Henan Provinces, with a total reactor capacity of 6,000 cubic meters. The quality system has been approved by the NMPA, PMDA, and U.S. FDA, providing customers with key starting materials, GMP intermediates, APIs, and CDMO services.